The Fred Hutchinson Cancer Research Center together with its partners the University of Washington, Seattle Children's Hospital and the Seattle Cancer Consotrium Alliance form the Fred Hutchinsonr/University of Washington Cancer Consortium. The Fred Hutchinson Cancer Research Center attracts preeminent researchers in the field of cancer research and treatment, HIV/AIDS and other diseases. On board on three Nobel Laureates, a MacArthur Fellow, six members of the Institute of Medicine and other award winning physticans and researchers. The Vaccine and Infectious Disease Institute is noteworthy. The Center is located in Seattle, Washington.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A new, multicenter study led by Fred Hutchinson Cancer Research Center and Memorial Sloan Kettering Cancer Center determined how a single mutation in splicing factor 3b subunit 1 (SF3B1), the most frequently mutated splicing ...
Oct 09, 2019
0
35
A team led by researchers at Fred Hutchinson Cancer Research Center has identified several women's health benefits from a low-fat diet. The findings, published in the September issue of the Journal of Nutrition, found a low-fat ...
Sep 04, 2019
0
2
In a paper published in the July 31 issue of Science Translational Medicine, researchers at Fred Hutchinson Cancer Research Center used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed ...
Jul 31, 2019
0
87
A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients. The study, published today ...
Jul 18, 2019
0
2
A new multicenter analysis led by researchers at the Fred Hutchinson Cancer Research Center, the Icahn School of Medicine at Mount Sinai and other institutions found the inclusion of diverse, multiethnic populations in large-scale ...
Jun 19, 2019
1
16
The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug ...
Jun 03, 2019
0
11
The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk published today in the New England Journal of Medicine. The study found ...
Feb 20, 2019
0
1
A research team led by the Fred Hutchinson Cancer Research Center have determined the most significant barriers to clinical trial participation. The study published today in Journal of the National Cancer Institute (JNCI) ...
Feb 19, 2019
0
192
A new study in Science challenges long-held theories of why a common virus—cytomegalovirus, or CMV—can reactivate and become a life-threatening infection in people with a compromised immune system, including blood cancer ...
Jan 17, 2019
0
124
The most comprehensive genome-wide association study, or GWAS, of colorectal cancer risk to date, published today in Nature Genetics, has discovered 40 new genetic variants and validated 55 previously identified variants ...
Dec 03, 2018
0
115
